NCT06046846 is a NA clinical trial of Asensei app in Oesophageal Cancer, sponsored by Queen Margaret University.

Who is sponsoring NCT06046846?

NCT06046846 is sponsored by Queen Margaret University.

What drugs are being tested in NCT06046846?

Interventions in NCT06046846: Asensei app.

What condition does NCT06046846 study?

NCT06046846 studies Oesophageal Cancer, Gastric Cancer, Prehabilitation, mHealth Application.

Is NCT06046846 still recruiting?

NCT06046846 is currently status unknown. Last updated 21 September 2023.

Last reviewed 2023-09-21 · How we verify

NCT06046846

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prehabilitation Via a Mobile Application in Oesophago-gastric Cancer

Status unknown NA Last updated 21 September 2023

What this trial tests

NA trial testing Asensei app in Oesophageal Cancer in 20 participants. Status unknown.

Timeline

1 November 2023

Primary endpoint
1 January 2025

1 January 2025

Quick facts

Lead sponsor	Queen Margaret University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	20
Start date	1 November 2023
Primary completion	1 January 2025
Estimated completion	1 January 2025

Drugs / interventions tested

Asensei app

Conditions studied

Oesophageal Cancer — all drugs for Oesophageal Cancer →
Gastric Cancer — all drugs for Gastric Cancer →
Prehabilitation — all drugs for Prehabilitation →
mHealth Application — all drugs for mHealth Application →

Sponsor

Queen Margaret University

Who can join

18 and older, any sex, with Oesophageal Cancer or Gastric Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall aim of this study is to assess the feasibility of a mHealth prehabilitation programme delivered via a mobile app for people with oesophago-gastric cancer by evaluating its user satisfaction and acceptance. The research question asks what is the feasibility of a mHealth prehabilitation programme delivered via a mobile app for patients with oesophago-gastric cancer? The primary aim of this single centred feasibility randomised controlled trial (RCT) is to explore the recruitment, adherence, and compliance of taking part in a mHealth prehabilitation programme delivered for 6 weeks via a mobile app prior to oesophago-gastric surgery. This study will develop a prehabilitation programme to investigate the feasibility and impact of delivering prehabilitation via a mobile app to patients with a diagnosis of oesophago-gastric cancer before surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Oesophageal Cancer

Currently open trials in the same condition.

NCT06906887 — PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer · Phase 2 · recruiting
NCT06422403 — A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers · Phase 2 · recruiting
NCT06364553 — Esophageal Self-expandable Metal Stent for Malignant Strictures: a Safety and Efficacy Study · NA · recruiting
NCT06440174 — Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients with Oesophageal Cancer (VALUE) · recruiting
NCT06212700 — PRIORITY-CONNECT 2 Pilot Trial · NA · recruiting

Other Queen Margaret University trials

Trials by the same sponsor.

NCT06911151 — Innovative Shoe for People With Foot Drop · NA · not yet recruiting
NCT05453656 — Development and Testing of the Kidney BEAM-KIDS Digital Platform for Children After Kidney Transplantation · NA · unknown
NCT05137691 — Health After Birth Intervention Trial · NA · terminated
NCT05234879 — The Feasibility of Frame Running as an Exercise Option for People With Multiple Sclerosis · NA · completed
NCT05252104 — Inter-rater Reliability of Diagnosing Thoracic Outlet Syndrome by Physiotherapists · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06046846 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Queen Margaret University
Last refreshed: 21 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06046846.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing